Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
So logically thinking,
Our Antibody test will sell out first before all the others every time :)
Spock
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
AbC-19TM rapid antibody test performance data
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes
the press release issued today by the UK Rapid Test Consortium ("UK-RTC"), of which Omega is a partner, welcoming a pre-print publication, funded by Public Health England (PHE), reviewing performance data on rapid antibody tests including the AbC-19TM Rapid Test.
The study, performed by scientists at PHE, and the Universities of Bristol, Warwick and Cambridge, examined the performance of four lateral flow rapid antibody tests using the same cohort of sample, and shows that the AbC-19TM is highly accurate when tested on samples from individuals previously positive for the virus by PCR and from samples collected pre-pandemic.
All devices tested had accuracy of above 92% with the AbC-19 TM Rapid Test showing the highest accuracy at 97.3%. The study remains subject to peer review.
The AbC-19TM Rapid test c onfirms the presence of SARS-CoV-2 IgG neutralising antibodies to the spike protein of the COVID-19 virus in a small blood sample. These neutralizing antibodies may be produced as part of the body's immune response following COVID-19 infection or post-vaccination. They not only bind to a virus, but they bind in a manner that blocks infection.
Professor Chris Molloy, Chair of the UK-RTC, said: "This research on the different use cases for lateral flow antibody tests is welcome. The AbC-19 TM test is an important weapon in the global fight against COVID-19. It allows us to see the neutralising IgG antibodies produced in response to infection, or after vaccination."
Very well explained Tricky
Once approval is granted, there will be more than 27 countries wanting in.
That's for sure
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes today's update from Abingdon Health plc (AIM: ABDX) regarding the AbC-19TM Rapid Test and welcomes confirmation that they continue to work constructively with the Medicines and Healthcare products Regulatory Agency (MHRA) to try to enable approval for home use and self-test of the AbC-19TM Rapid Test in the UK.
Abingdon have also confirmed that whilst the DHSC continues to have first refusal for supplies of the AbC-19TM Rapid Test through a Supply of Goods Contract that extends to 14 February 2021, the UK-RTC is liaising with customers and regulatory authorities across a total of 27 international territories, to allow future use of the product outside of the UK.
Colin King, CEO of Omega Diagnostics, said: "We welcome the update from Abingdon Health this morning and we look forward to being able to update investors on this approval process for self-test use in due course. We remain confident that the AbC-19TM Rapid Test has a potential global application and we are delighted that the UK-RTC maintains constructive dialogue with interested customers and regulatory authorities across the world."
Don't forget trading ends at 12:30 UK time today
Rns
This is going to Boooom big time.
Buy, chill and relax.....
You would think they would have given priority and fast track the approval as the economy is on its knees, not to mention all the other issues associated with this virus?
??
I'm sure its the feed from the London Stock Exchange, not LSE here.
Clown?
You do realise its project warp speed that made the FDA accept in record time.
UK/RTC partnership agreement states that 25% has to be manufactured by Omega
So, it is great news actually !
Fleeced to get their mates rates,
Crooks